Article Text

Download PDFPDF
Specific cell differentiation in breast cancer: a basis for histological classification
  1. Emad Rakha1,
  2. Michael Toss1,
  3. Cecily Quinn2,3
  1. 1School of Medicine, The University of Nottingham, Nottingham, UK
  2. 2Histopathology, St. Vincent's Hospital, Dublin, Ireland
  3. 3Belfield, University College Dublin - National University of Ireland, Dublin, Ireland
  1. Correspondence to Professor Emad Rakha, School of Medicine, The Unversity of Nottingham and Nottingham University Hospitals NHS Trust, Nottingham NG5 1PB, UK; emad.rakha{at}nottingham.ac.uk

Abstract

Breast parenchyma progenitor cells show a high degree of phenotypic plasticity reflected in the wide range of morphology observed in benign and malignant breast tumours. Although there is evidence suggesting that all breast cancer (BC) arises from a common epithelial progenitor or stem cell located at the terminal duct lobular units (TDLUs), BC shows a broad spectrum of morphology with extensive variation in histological type and grade. This is related to the complexity of BC carcinogenesis including initial genetic changes in the cell of origin, subsequent genetic and epigenetic alterations and reprogramming that occur at various stages of BC development and the interplay with the surrounding microenvironment, factors which influence the process of differentiation. Differentiation in BC determines the morphology, which can be measured using histological grade and tumour type. Histological grade, which measures the similarity to the TDLUs, reflects the degree of differentiation whereas tumour type reflects the type of differentiation. Understanding BC phenotypic differentiation facilitates the accurate diagnosis and histological classification of BC with corresponding clinical implications in terms of disease behaviour, prognosis and management plans. In this review, we highlight the potential pathways that BC stem cells follow resulting in the development of different histological types of BC and how knowledge of these pathways impacts our ability to classify BC in diagnostic practice. We also discuss the role of cellular differentiation in producing metaplastic and neuroendocrine carcinomas of the breast and how the latter differ from their counterparts in other organs, with emphasis on clinical relevance.

  • breast neoplasms
  • cell differentiation
  • morphological and microscopic findings

Statistics from Altmetric.com

Footnotes

  • Handling editor Cheok Soon Lee.

  • Contributors All authors contributed to the idea and writing the review.

  • Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.

  • Competing interests None declared.

  • Provenance and peer review Not commissioned; internally peer reviewed.

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.